Your browser doesn't support javascript.
loading
Suppressor of Ty 16 promotes lung cancer malignancy and is negatively regulated by miR-1227-5p.
Yang, Lu; Wang, Xing; Jiao, Xinyan; Tian, Bixia; Zhang, Miao; Zhou, Can; Wang, Ruiqi; Chen, He; Wang, Bo; Li, Juan; Liu, Jie; Zhang, Guanjun; Liu, Peijun.
Afiliação
  • Yang L; Center for Translational Medicine, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Wang X; Key Laboratory for Tumor Precision Medicine of Shaanxi Province, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Jiao X; Department of Pathology, First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China.
  • Tian B; Center for Translational Medicine, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Zhang M; Key Laboratory for Tumor Precision Medicine of Shaanxi Province, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Zhou C; Center for Translational Medicine, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Wang R; Key Laboratory for Tumor Precision Medicine of Shaanxi Province, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Chen H; Center for Translational Medicine, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Wang B; Key Laboratory for Tumor Precision Medicine of Shaanxi Province, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Li J; Department of Breast Surgery, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Liu J; Center for Translational Medicine, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Zhang G; Key Laboratory for Tumor Precision Medicine of Shaanxi Province, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Liu P; Center for Translational Medicine, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Cancer Sci ; 111(11): 4075-4087, 2020 Nov.
Article em En | MEDLINE | ID: mdl-32860308
ABSTRACT
Suppressor of Ty 16 (Spt16) is a component of the facilitates chromatin transcription (FACT) complex, which is a histone chaperone and involved in gene transcription, DNA replication, and DNA repair. Previous studies showed that FACT is highly expressed in cancer, and cancer cells are more reliant on FACT than normal cells. However, the relationship between Spt16 and lung cancer remains unclear. In this study, we explored the functions of Spt16 in lung cancer cells. The effects of Spt16 on lung cancer cell proliferation, cell cycle progression, apoptosis, migration, and invasion were examined. We found that knockdown of Spt16 led to obvious decreases of both Rb and MCM7, and further activated the DNA damage response (DDR) pathway. In addition, a novel micro-RNA, miR-1227-5p, directly targeted the 3'-UTR of Spt16 and regulated the mRNA levels of Spt16. Furthermore, we found that CBL0137, the functional inhibitor of FACT, showed similar effects as loss of Spt16. Together, our data indicated that Spt16 is likely to be an essential regulator for lung cancer malignancy and is negatively regulated by miR-1227-5p.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Regulação Neoplásica da Expressão Gênica / Proteínas de Ciclo Celular / MicroRNAs / Neoplasias Pulmonares Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Regulação Neoplásica da Expressão Gênica / Proteínas de Ciclo Celular / MicroRNAs / Neoplasias Pulmonares Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article